LumiThera Acquires MacuLogix Assets (AdaptDx Pro)
July 26, 2022
LumiThera, through a wholly owned subsidiary, purchased the assets of MacuLogix, including the AdaptDx Pro dark adaptometer used for early diagnosis of dry age-related macular degeneration (AMD). The acquisition expands LumiThera's diagnostic and monitoring capabilities and complements its Valeda photobiomodulation treatment platform for dry AMD patients.
- Buyers
- LumiThera, Inc.
- Targets
- MacuLogix, Inc.
- Sellers
- MacuLogix, Inc.
- Industry
- Medical Devices
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
MyEyeDr Acquires Lumina Vision Partners to Expand Doctor-Led Optometry Footprint in Southwest
April 22, 2026
Healthcare Services
MyEyeDr announced the acquisition of Lumina Vision Partners, a 28-location optometry practice group in Arizona and Texas. The deal expands MyEyeDr’s doctor-led vision care footprint and builds on its buy-and-build growth strategy in the U.S.
-
Alcon to Acquire LumiThera
July 7, 2025
Medical Devices
Alcon, a leader in eye care, plans to acquire LumiThera, which develops light-based therapies for ophthalmology, including its photobiomodulation (PBM) device for treating early and intermediate dry age-related macular degeneration (AMD). The acquisition is expected to close in the third quarter of 2025, subject to customary closing conditions and a LumiThera shareholder vote.
-
Somatus Acquires Strategic Assets from Lumiata
April 28, 2022
Healthcare Services
Somatus has acquired strategic assets from Lumiata to integrate Lumiata's healthcare AI and predictive analytics into Somatus' RenalIQ platform, improving early identification of people with chronic kidney disease and prediction of disease progression. The deal brings Lumiata talent (including Jessica McCarthy) into Somatus and aims to strengthen care delivery, reduce costs for provider and health-plan partners, and address health inequities.
-
LumiThera Acquires Diopsys
November 11, 2021
Medical Devices
LumiThera, a commercial-stage ophthalmic medical device company, entered a definitive merger agreement to acquire Diopsys in a stock-for-stock transaction under which Diopsys will become a wholly owned subsidiary of LumiThera. The deal combines Diopsys' visual electrophysiology diagnostic systems with LumiThera's photobiomodulation treatment platform to create a coordinated light-based theranostic approach for diagnosing, treating and monitoring ocular disease.
-
AdaptHealth Acquires Solara Medical Supplies from Linden Capital Partners
May 26, 2020
Healthcare Services
AdaptHealth Corp. has agreed to acquire Solara Medical Supplies, LLC from Linden Capital Partners, adding the largest independent U.S. distributor of continuous glucose monitors and other diabetes supplies to AdaptHealth's in-home medical supplies platform. The transaction is being funded with a combination of debt and equity commitments (including investments from One Equity Partners and Deerfield Management) and will see Solara's CEO Steve Foreman join AdaptHealth's leadership team.
-
DiscernDx Acquires Luminist Labs
April 29, 2020
Biotechnology
DiscernDx, a Palo Alto precision medicine company, has acquired Luminist Labs, a privately-held diagnostic platform developer focused on early detection and diagnosis of liver disease. The acquisition will integrate Luminist's data and platform into DiscernDx's multi-omics system to accelerate development of non-invasive diagnostic and prognostic solutions for NASH and other chronic metabolic liver diseases. Terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.